In this webinar, Dr. Emma Gibbin-Lameira will show how Nanolive’s label-free, non-invasive imaging can be used to quantify dose-dependent responses of HeLa cells to Chloroquine.
Specifically, Dr. Gibbin-Lameira will show that:
- Dose-dependent experiments can be performed in 96-well plate format over long periods of time (> 2 days), reducing the need for time and labor-intensive multiple fixed-point measurements and eliminating cytotoxic/cytostatic effects arising from the use of labels, dyes, or phototoxic damage
- Metrics output from Nanolive’s proprietary software, EVE Analytics, can be used to generate statistically robust time-dependent EC50 values based on total dry mass; a metric unique to label-free imaging
- Sub-cellular spatial resolution combined with high content image analysis can be used to investigate a drugs’ mechanism of action
Please register below to watch the webinar on-demand.
Read our latest news
Nanolive at the SPS Annual Meeting September 18-20
Joint presentation with Sanofi Nanolive is delighted to invite for you to attend our upcoming joint presentation with Sanofi at the Safety Pharmacology Society (SPS) Annual Meeting in Brussels on September 20, 2023, from 12:30 PM to 1:30 PM in Studio 214. During our...
Webinar – High content in vitro imaging for translational success: targeted therapies
Nanolive hosts this event on "Non-invasive, high content live cell assays to increase translational relevance of in vitro drug development of biologics and small molecules". In this webinar, we present the following use-cases of our immuno-oncology and cytotoxicity...
Nanolive empowers groundbreaking ferroptosis research published in Nature
Congratulations to the Conrad lab for their latest Nature paper 'Phase separation of FSP1 promotes ferroptosis'! This beautiful capture published as part of the paper provides new information about the events leading up to ferroptotic cell death. Using refractive...